Los puntos clave no están disponibles para este artículo en este momento.
Poor biologic persistence was associated with increased non-medication-associated HCRU. Effective treatments with high persistence levels and limited associated HCRU are needed in UC.
Bargo et al. (Fri,) studied this question.